EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine
EpiVax is joining Intravacc and CEPI on a new project to develop universal vaccines for betacoronaviruses, including SARS-CoV-2.
Stay updated with breaking news from Outer Membrane Vesicle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EpiVax is joining Intravacc and CEPI on a new project to develop universal vaccines for betacoronaviruses, including SARS-CoV-2.
/PRNewswire/ -- CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc,...
Avacc 101 vaccine candidate will be designed to provide broad protection against SARS-CoV-1, SAR-CoV-2, and MERS-CoV